Taisho said to near $1.6 billion deal for Bristol-Myers's UPSA - Bloomberg
Share:
(Reuters) - Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd is said to be close to a $1.6 billion (1.3-billion pound) deal for Bristol-Myers Squibb Co's French over-the-counter drugs business UPSA, Bloomberg reported on Sunday, citing sources familiar with the matter.An agreement for the consumer-health business could be announced as soon as this week, according to the report https://bloom.bg/2QyHulF.Bristol-Myers Squibb declined to comment on the report, but said it was still..